TrialCancer immunology, immunotherapy : CII2010

A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer.

Anda M Vlad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.